• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中左旋多巴诱导的异动症的正电子发射断层扫描分子成像研究

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.

作者信息

Pagano Gennaro, Yousaf Tayyabah, Politis Marios

机构信息

Neurodegeneration Imaging Group, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology & Neuroscience, King's College London, 125 Coldharbour Lane, London, Camberwell, SE5 9NU, UK.

出版信息

Curr Neurol Neurosci Rep. 2017 Oct 3;17(11):90. doi: 10.1007/s11910-017-0794-2.

DOI:10.1007/s11910-017-0794-2
PMID:28975571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5626800/
Abstract

PURPOSE OF REVIEW

To review the current status of positron emission tomography (PET) molecular imaging research of levodopa-induced dyskinesias (LIDs) in Parkinson's disease (PD).

RECENT FINDINGS

Recent PET studies have provided robust evidence that LIDs in PD are associated with elevated and fluctuating striatal dopamine synaptic levels, which is a consequence of the imbalance between dopaminergic and serotonergic terminals, with the latter playing a key role in mishandling presynaptic dopamine release. Long-term exposure to levodopa is no longer believed to solely induce LIDs, as studies have highlighted that PD patients who go on to develop LIDs exhibit elevated putaminal dopamine release before the initiation of levodopa treatment, suggesting the involvement of other mechanisms, including altered neuronal firing and abnormal levels of phosphodiesterase 10A. Dopaminergic, serotonergic, glutamatergic, adenosinergic and opioid systems and phosphodiesterase 10A levels have been shown to be implicated in the development of LIDs in PD. However, no system may be considered sufficient on its own for the development of LIDs, and the mechanisms underlying LIDs in PD may have a multisystem origin. In line with this notion, future studies should use multimodal PET molecular imaging in the same individuals to shed further light on the different mechanisms underlying the development of LIDs in PD.

摘要

综述目的

回顾帕金森病(PD)中左旋多巴诱导的异动症(LIDs)的正电子发射断层扫描(PET)分子成像研究现状。

最新发现

近期的PET研究提供了有力证据,表明PD中的LIDs与纹状体多巴胺突触水平升高和波动有关,这是多巴胺能和5-羟色胺能终末之间失衡的结果,后者在处理突触前多巴胺释放不当方面起关键作用。长期接触左旋多巴不再被认为是单独诱发LIDs的原因,因为研究强调,继续发展为LIDs的PD患者在开始左旋多巴治疗前壳核多巴胺释放就已升高,这表明其他机制也参与其中,包括神经元放电改变和磷酸二酯酶10A水平异常。多巴胺能、5-羟色胺能、谷氨酸能、腺苷能和阿片样物质系统以及磷酸二酯酶10A水平已被证明与PD中LIDs的发生有关。然而,没有一个系统单独就足以导致LIDs的发生,PD中LIDs的潜在机制可能有多个系统起源。与此观点一致,未来的研究应在同一患者中使用多模态PET分子成像,以进一步阐明PD中LIDs发生的不同机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8507/5626800/e773cfe03645/11910_2017_794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8507/5626800/e773cfe03645/11910_2017_794_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8507/5626800/e773cfe03645/11910_2017_794_Fig1_HTML.jpg

相似文献

1
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.帕金森病中左旋多巴诱导的异动症的正电子发射断层扫描分子成像研究
Curr Neurol Neurosci Rep. 2017 Oct 3;17(11):90. doi: 10.1007/s11910-017-0794-2.
2
The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies.帕金森病伴运动障碍患者的 5-羟色胺能系统:影像学研究证据。
J Neural Transm (Vienna). 2018 Aug;125(8):1217-1223. doi: 10.1007/s00702-017-1823-7. Epub 2017 Dec 20.
3
Molecular imaging of levodopa-induced dyskinesias.左旋多巴诱发异动症的分子成像
Cell Mol Life Sci. 2015 Jun;72(11):2107-17. doi: 10.1007/s00018-015-1854-x. Epub 2015 Feb 15.
4
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.导致帕金森病患者左旋多巴诱导运动障碍的血清素能机制。
J Clin Invest. 2014 Mar;124(3):1340-9. doi: 10.1172/JCI71640. Epub 2014 Feb 17.
5
Dyskinesias in Parkinson's disease: views from positron emission tomography studies.帕金森病中的异动症:正电子发射断层扫描研究的观点
Eur J Neurol. 2014 May;21(5):694-9, e39-43. doi: 10.1111/ene.12362. Epub 2014 Jan 28.
6
The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.苍白球5-羟色胺能功能在帕金森病异动症中的作用:一项正电子发射断层扫描研究。
Neurobiol Aging. 2015 Apr;36(4):1736-1742. doi: 10.1016/j.neurobiolaging.2014.12.037. Epub 2015 Jan 6.
7
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.左旋多巴引起的突触多巴胺水平变化随帕金森病进展而增加:对运动障碍的影响。
Brain. 2004 Dec;127(Pt 12):2747-54. doi: 10.1093/brain/awh290. Epub 2004 Aug 25.
8
Altered brain structural topological properties in Parkinson's disease with levodopa-induced dyskinesias.左旋多巴诱导异动症帕金森病患者脑结构拓扑性质的改变。
Parkinsonism Relat Disord. 2019 Oct;67:36-41. doi: 10.1016/j.parkreldis.2019.09.022. Epub 2019 Sep 19.
9
Drug-induced dyskinesias.药物性运动障碍
Curr Opin Neurol. 2009 Aug;22(4):394-9. doi: 10.1097/WCO.0b013e32832d9dc4.
10
Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.帕金森病和左旋多巴诱导运动障碍中的血清素标志物。
Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4.

引用本文的文献

1
CSF phospho-tau levels at Parkinson's disease onset predict the risk for development of motor complications.帕金森病发病时脑脊液磷酸化tau蛋白水平可预测运动并发症的发生风险。
J Neurol. 2025 Aug 13;272(9):573. doi: 10.1007/s00415-025-13325-4.
2
Repetitive Levodopa Treatment Drives Cell Type-Specific Striatal Adaptations Associated With Progressive Dyskinesia in Parkinsonian Mice.重复左旋多巴治疗导致帕金森病小鼠纹状体细胞类型特异性适应性变化,与进行性运动障碍相关。
bioRxiv. 2025 May 21:2025.05.16.654598. doi: 10.1101/2025.05.16.654598.
3
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.

本文引用的文献

1
An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease.金刚烷胺治疗帕金森病异动症的最新荟萃分析。
Oncotarget. 2017 May 5;8(34):57316-57326. doi: 10.18632/oncotarget.17622. eCollection 2017 Aug 22.
2
Locus coeruleus.蓝斑。
Cell Tissue Res. 2018 Jul;373(1):221-232. doi: 10.1007/s00441-017-2649-1. Epub 2017 Jul 7.
3
Diagnosis and Management of Parkinson's Disease.帕金森病的诊断与管理
左旋多巴治疗:贯穿帕金森病进展过程中的影响及机制。
J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02893-4.
4
The Interaction of Histamine H and Dopamine D Receptors on Hyperkinetic Alterations in Animal Models of Parkinson's Disease.帕金森病动物模型中组胺H受体与多巴胺D受体相互作用对运动亢进改变的影响
Pharmaceuticals (Basel). 2024 Dec 20;17(12):1726. doi: 10.3390/ph17121726.
5
Neuroinflammation and Dyskinesia: A Possible Causative Relationship?神经炎症与运动障碍:一种可能的因果关系?
Brain Sci. 2024 May 20;14(5):514. doi: 10.3390/brainsci14050514.
6
Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies.左旋多巴诱导的帕金森病运动障碍:发病机制与新兴治疗策略。
Cells. 2022 Nov 23;11(23):3736. doi: 10.3390/cells11233736.
7
Serotonin-Related Functional Genetic Variants Affect the Occurrence of Psychiatric and Motor Adverse Events of Dopaminergic Treatment in Parkinson's Disease: A Retrospective Cohort Study.血清素相关功能基因变异影响帕金森病多巴胺能治疗中精神和运动不良事件的发生:一项回顾性队列研究。
J Pers Med. 2022 Feb 11;12(2):266. doi: 10.3390/jpm12020266.
8
Graph Theory on Brain Cortical Sources in Parkinson's Disease: The Analysis of 'Small World' Organization from EEG.脑皮质源帕金森病的图论研究:来自 EEG 的“小世界”组织分析。
Sensors (Basel). 2021 Oct 31;21(21):7266. doi: 10.3390/s21217266.
9
Positron emission tomography/computed tomography dual imaging using 18-fluorine flurodeoxyglucose and 11C-labeled 2-β-carbomethoxy-3-β-(4-fluorophenyl) tropane for the severity assessment of Parkinson disease.使用18氟氟脱氧葡萄糖和11C标记的2-β-甲氧基羰基-3-β-(4-氟苯基)托烷进行正电子发射断层扫描/计算机断层扫描双成像用于帕金森病严重程度评估
Medicine (Baltimore). 2020 Apr;99(14):e19662. doi: 10.1097/MD.0000000000019662.
10
Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced Dyskinesia.左旋多巴诱导性异动症实验性治疗方法的最新进展
J Mov Disord. 2019 Sep;12(3):161-165. doi: 10.14802/jmd.19029. Epub 2019 Sep 30.
Semin Neurol. 2017 Apr;37(2):118-126. doi: 10.1055/s-0037-1601888. Epub 2017 May 16.
4
Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.用于活化小胶质细胞PET成像的分子靶点:现状与未来展望
Int J Mol Sci. 2017 Apr 11;18(4):802. doi: 10.3390/ijms18040802.
5
Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies.帕金森病中的 5-羟色胺转运体:正电子发射断层扫描研究的荟萃分析。
Ann Neurol. 2017 Feb;81(2):171-180. doi: 10.1002/ana.24859.
6
Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory.从蓝斑核向背侧海马体释放的多巴胺可促进空间学习和记忆。
Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14835-14840. doi: 10.1073/pnas.1616515114. Epub 2016 Dec 7.
7
l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?左旋多巴诱发的运动障碍与神经炎症:小胶质细胞和星形胶质细胞起作用吗?
Eur J Neurosci. 2017 Jan;45(1):73-91. doi: 10.1111/ejn.13482. Epub 2016 Dec 9.
8
Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain.[(11)C]MENET与健康人脑中去甲肾上腺素转运体结合的房室模型
Nucl Med Biol. 2016 May;43(5):318-23. doi: 10.1016/j.nucmedbio.2016.02.008. Epub 2016 Feb 28.
9
Cholinergic imaging in dementia spectrum disorders.痴呆谱系障碍中的胆碱能成像
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1376-86. doi: 10.1007/s00259-016-3349-x. Epub 2016 Mar 16.
10
Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias.帕金森病中5-羟色胺与多巴胺转运体比率:与运动障碍的相关性。
Neurology. 2016 Mar 22;86(12):1152-8. doi: 10.1212/WNL.0000000000002494. Epub 2016 Feb 26.